NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of…Read More

You might also be interested in reading India’s Crypto Trading Volume Plunges Further as Mobikwik Stops Payment Service.